<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the plasma levels of endogenous <z:chebi fb="0" ids="16136">hydrogen sulfide</z:chebi> (<z:chebi fb="12" ids="16136,29324,36945">H2S</z:chebi>), a gasotransmitter, and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) in patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD), and cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) and their role in the pathogenesis of AD and VD </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: 31 AD patients, 28 VD patients, 20 CVD patients , and 23 <z:mpath ids='MPATH_458'>normal</z:mpath> controls (NC group) underwent examination of plasma concentrations of <z:chebi fb="12" ids="16136,29324,36945">H2S</z:chebi> and <z:chebi fb="0" ids="17230">Hcy</z:chebi>, mini mental state examination (MMSE), activity of daily living scale (ADL), Hachinski ischemic score (HIS) , and Hamilton's <z:hpo ids='HP_0000716'>depression</z:hpo> scale (HRSD) </plain></SENT>
<SENT sid="2" pm="."><plain>The severity of AD and VD was evaluated according to the global deterioration scale (GDS) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: (1) The plasma <z:chebi fb="12" ids="16136,29324,36945">H2S</z:chebi> levels of the AD, VD, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> patients were (34 +/- 7), (36 +/- 5), and (37 +/- 7) micromol/L respectively, <z:hpo ids='HP_0000001'>all</z:hpo> significantly lower than that of the NC group [(45 +/- 7) micromol/L, <z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.01] </plain></SENT>
<SENT sid="4" pm="."><plain>However, there were no significant differences in the plasma <z:chebi fb="12" ids="16136,29324,36945">H2S</z:chebi> level among the AD, VD, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> patients (<z:hpo ids='HP_0000001'>all</z:hpo> P &gt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>The plasma <z:chebi fb="12" ids="16136,29324,36945">H2S</z:chebi> concentration was negatively correlated the severity of AD </plain></SENT>
<SENT sid="6" pm="."><plain>(2) The plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels of the AD, VD, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> patients were (14.0 +/- 3.0), (16.0 +/- 6.1), and (14.4 +/- 4.9) micromol/L respectively, <z:hpo ids='HP_0000001'>all</z:hpo> significantly higher than that of the NC group [(9.8 +/- 2.5) micromol/L, P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>However, there was no significant difference in the plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> level among these 3 groups (<z:hpo ids='HP_0000001'>all</z:hpo> P &gt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>The plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> concentration was positively correlated with the severity of AD or VD </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: <z:chebi fb="12" ids="16136,29324,36945">H2S</z:chebi> and <z:chebi fb="0" ids="17230">Hcy</z:chebi> are both involved in the pathogenesis of AD, VD, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, and its alteration in level may be associated with the severity of AD and VD </plain></SENT>
</text></document>